Last update:
Oncology news
Cutting-edge drug shows promise for patients with NRAS-driven melanoma
A research team from Huntsman Cancer Institute at the University of Utah (the U) reports that a pathway-targeted therapy could be an effective treatment for certain melanoma patients and fill an unmet clinical need for patients ...
7 hours ago
0
4
Cancer survivors and providers differ in views on medical cannabis, study finds
For many cancer survivors, cannabis has become part of how they manage symptoms such as pain, nausea and anxiety. Medical cannabis is now legal in 47 states, Washington, D.C., and three U.S. territories, and its use continues ...
4 hours ago
0
1
New imaging method tracks cancer from whole body to individual cells
One of the biggest challenges in cancer research has been linking the "big picture" seen in medical scans with the microscopic biology that drives tumor growth and dictates how patients respond to treatment. Now, by combining ...
Jul 17, 2026
0
110
LIG1 loss exposes a therapeutic vulnerability in triple-negative breast cancer
Loss of one copy of the DNA ligase I (LIG1) gene in triple-negative breast cancers (TNBC) with TP53 mutations confers resistance to chemotherapy, but researchers at Baylor College of Medicine and collaborating institutions ...
Jul 17, 2026
0
15
Microbiota dysbiosis triggers intestinal cancer stemness
Scientists at National Taiwan University College of Medicine have discovered that cancer formation is not simply caused by gene mutations. Colorectal cancers primarily originate from epithelial cells that form adenocarcinomas ...
Jul 17, 2026
0
3
No evidence mobile phones cause brain cancer—new study
Electromagnetic waves are everywhere. They're the reason you can hear music when you turn on the radio, use Wi-Fi, find your way using satellite navigation, and make calls on a mobile phone. They are a form of electromagnetic ...
Jul 17, 2026
0
5
Early inflammation signal drives oral cancer development, highlights path for immunoprevention
Researchers at The University of Texas MD Anderson Cancer Center identified an immune pathway that may promote the progression of oral precancerous lesions into head and neck squamous cell carcinoma. These results provide ...
Jul 17, 2026
0
5
Immune receptor plays dual role in promoting T-cell exhaustion in cancer
A new Northwestern Medicine study has uncovered how a key immunoregulatory receptor plays an unexpected dual role in promoting T-cell exhaustion during chronic infection and cancer, according to findings published in the ...
Jul 16, 2026
0
23
Blood gene test detects 90% of early-stage pancreatic cancers
Researchers at Kanazawa University report that blood-based gene expression tests may enable early pancreatic cancer screening and improve long-term survival.
Jul 16, 2026
0
10
Researchers identify immune cell that builds cancer-fighting hubs inside tumors
Researchers at the Icahn School of Medicine at Mount Sinai have identified the immune cell that acts as the architect and coordinator of powerful immune hubs that form inside tumors and plays a key role in antitumor immunity. ...
Jul 16, 2026
0
4
Immune cells use previously unknown pathway to eliminate acute myeloid leukemia
Researchers at The University of Texas MD Anderson Cancer Center have discovered a new way in which T cells attack acute myeloid leukemia (AML) cells, which may help explain why AML is particularly sensitive to immune-based ...
Jul 16, 2026
0
6
MicroRNA discovery points to new strategy for slowing lung cancer growth
Cancer develops when the body's systems for controlling cell growth break down, allowing cells to multiply unchecked. Texas A&M researchers have identified two naturally occurring molecules that appear to help restore those ...
Jul 16, 2026
0
8
Deleting two molecular gatekeepers sharply reduces metastasis in mouse tumors
By analyzing individual cancer cells, researchers from the Université Libre de Bruxelles (ULB) discovered the transcriptional regulators governing epithelial-to-mesenchymal transition (EMT) in tumors and identified key master ...
Jul 16, 2026
0
5
Targeting RBM5 may help disrupt 'undruggable' MYC in childhood leukemia
Scientists from St. Jude Children's Research Hospital and collaborators have identified the RNA-binding protein RBM5 as a potential vulnerability in a set of difficult-to-treat childhood leukemias. They characterized how ...
Jul 16, 2026
0
3
Study reveals why some colorectal cancers respond better to immunotherapy
A subset of cancers, known as microsatellite instability (MSI) and deficient DNA mismatch repair (dMMR) cancers, are more visible to the immune system than others. Because their DNA repair systems are defective, these tumors ...
Jul 16, 2026
0
4
Stopping myeloma maintenance after two years shows no survival loss in trial
For patients with newly diagnosed multiple myeloma not undergoing an autologous stem cell transplant, indefinite lenalidomide maintenance has long been standard care despite limited evidence to guide the optimal duration ...
Jul 16, 2026
0
4
Impact of overweight on cancer risk may be significantly underestimated
Being overweight and obesity may contribute to significantly more cancer cases than previously thought. This is the conclusion reached by researchers at the German Cancer Research Center (DKFZ). Their analysis shows that ...
Jul 16, 2026
0
5
Experimental pancreatic cancer vaccine elicits durable immune responses in high-risk participants
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer that is often diagnosed at advanced stages and carries a low five-year survival rate. Approximately 10% of cases are associated with hereditary predisposition ...
Jul 16, 2026
0
5
Clinical trial proves effectiveness of FLASH treatment for pain reduction in cancer patients
University of Cincinnati Cancer Center researchers led a first-of-a-kind clinical study showing that a cancer treatment known as FLASH, or ultra-high-dose-rate proton beam radiation therapy, safely and effectively reduced ...
Jul 16, 2026
0
4
New tool makes immune therapy more effective in prostate cancer
Prostate cancer is often resistant to immunotherapy, which harnesses a person's immune system to recognize and destroy tumors. But a new technology that targets RNA in cancer cells gave immunotherapy new life, improving its ...
Jul 15, 2026
0
378
Ketogenic diets may increase cancer risk in the small intestine
A high-fat, low-carbohydrate diet, also called a ketogenic diet, can help some people lose weight by forcing their bodies to burn fat for fuel instead of sugar.
Jul 15, 2026
0
39
Virtual tumor predicts response to liver cancer immunotherapy
Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to predict which patients with a primary liver cancer called hepatocellular ...
Jul 15, 2026
0
7
Shape-shifting drug hits tumors in multiple ways, improves outcomes in mice
Modern anticancer medications that combine tumor-fighting drugs with proteins that specifically target cancer cells are a relatively new class of drugs, often given to patients for whom standard chemotherapy has not worked. ...
Jul 15, 2026
0
6
Fertility proteins flip from reproductive role to support survival and growth of cancer cells
Researchers at the University of Liverpool have discovered that SYCP1, a protein previously thought to function only during the production of sperm and eggs, can be reactivated in cancer cells, where it helps tumors survive ...
Jul 15, 2026
0
5
Bile acid buildup drives spread of breast cancer, discovery reveals
A buildup of bile acids caused by an unhealthy gut can drive breast cancer to other parts of the body, new University of Virginia Comprehensive Cancer Center research reveals. The findings could open the door to new ways ...
Jul 15, 2026
0
9
